| [1] |
World Health Organization. Ageing and health[EB/OL]. [2025-08-16]. https://www.who.int/news-room/fact-sheets/detail/ageing-and-health.
|
| [2] |
国家统计局. 第七次全国人口普查公报解读[EB/OL]. (2021-05-12)[2025-08-16]. http://www.stats.gov.cn/tjsj/sjjd/202105/t20210512_1817336.html.
|
|
National Bureau of Statistics of China. Interpretation of the bulletin of the Seventh National Census[EB/OL]. (2021-05-12)[2025-08-16]. http://www.stats.gov.cn/tjsj/sjjd/202105/t20210512_1817336.html.
|
| [3] |
SI H, WANG C, JIN Y, et al. Prevalence, factors, and health impacts of chronic pain among community-dwelling older adults in China[J]. Pain Manag Nurs, 2019, 20(4): 365-372.
doi: S1524-9042(17)30397-1
pmid: 31103518
|
| [4] |
ZHU X, ZHANG X, DING L, et al. Associations of pain and sarcopenia with successful aging among older people in China: Evidence from CHARLS[J]. J Nutr Health Aging, 2023, 27(3): 196-201.
doi: 10.1007/s12603-023-1892-2
pmid: 36973927
|
| [5] |
LIN T, DAI M, XU P, et al. Prevalence of sarcopenia in pain patients and correlation between the two conditions: a systematic review and meta-analysis[J]. J Am Med Dir Assoc, 2022, 23(5): 902.e1-902.e20.
|
| [6] |
MARUYA K, FUJITA H, ARAI T, et al. Sarcopenia and lower limb pain are additively related to motor function and a history of falls and fracture in community-dwelling elderly people.[J]. Osteoporos Sarcopenia, 2019, 5(1): 23-26.
doi: 10.1016/j.afos.2019.03.002
pmid: 31008375
|
| [7] |
LIN T, HUANG X, GUO D, et al. Pain as a risk factor for incident sarcopenia in community-dwelling older adults: a 1-year prospective cohort study[J]. J Am Geriatr Soc, 2023, 71(2): 546-552.
doi: 10.1111/jgs.v71.2
|
| [8] |
NISHIKAWA H, FUKUNISHI S, ASAI A, et al. Pathophysiology and mechanisms of primary sarcopenia (review)[J]. Int J Mol Med, 2021, 48(2): 156.
|
| [9] |
LIAO C D, CHEN H C, HUANG M H, et al. Comparative efficacy of intra-articular injection, physical therapy, and combined treatments on pain, function, and sarcopenia indices in knee osteoarthritis: a network meta-analysis of randomized controlled trials[J]. Int J Mol Sci, 2023, 24(7): 6078.
|
| [10] |
DENG P, LIU C, CHEN M, et al. Knowledge domain and emerging trends in multimorbidity and frailty research from 2003 to 2023: a scientometric study using Citespace and VOSviewer[J]. Health Econ Rev, 2023, 13(1): 46.
|
| [11] |
CHEN J, WANG X, XU Z. Sarcopenia and chronic pain in the elderly: a systematic review and meta-analysis[J]. J Pain Res, 2023, 16: 3569-3581.
doi: 10.2147/JPR.S435866
pmid: 37908777
|
| [12] |
RODRÍGUEZ-LUMBRERAS L, RUIZ-CÁRDENAS J D, MURCIA-GONZÁLEZ M A. Risk of secondary sarcopenia in Europeans with fibromyalgia according to the EWGSOP2 guidelines: systematic review and meta-analysis[J]. Eur J Phys Rehabil Med, 2024, 60(4): 703-715.
|
| [13] |
LIAO C D, WU Y T, TSAUO J Y, et al. Effects of protein supplementation combined with exercise training on muscle mass and function in older adults with lower-extremity osteoarthritis: a systematic review and meta-analysis of randomized trials[J]. Nutrients, 2020, 12(8): 2422.
|
| [14] |
SMITH L, LÓPEZ SÁNCHEZ G F, VERONESE N, et al. Association between pain and sarcopenia among adults aged ≥65 years from low- and middle-income countries[J]. J Gerontol A Biol Sci Med Sci, 2023, 78(6): 1020-1027.
doi: 10.1093/gerona/glad002
|
| [15] |
CHEN J, YAN L, CHU J, et al. Pain characteristics and progression to sarcopenia in Chinese middle-aged and older adults: a 4-year longitudinal study[J]. J Gerontol A Biol Sci Med Sci, 2024, 79(5): glae080.
|
| [16] |
ZHOU S, LIU Y, ZHANG Y, et al. Association between persistent musculoskeletal pain and incident sarcopenia in China: the mediating effect of depressive symptoms[J]. Front Public Health, 2024, 12: 1416796.
doi: 10.3389/fpubh.2024.1416796
|
| [17] |
KIM H I, AHN S H, KIM Y, et al. Effects of sarcopenia and sarcopenic obesity on joint pain and degenerative osteoarthritis in postmenopausal women[J]. Sci Rep, 2022, 12(1): 13543.
|
| [18] |
DE KOCK R, GLADHILL K A, ALI M N, et al. How movements shape the perception of time[J]. Trends Cogn Sci, 2021, 25(11): 950-963.
doi: 10.1016/j.tics.2021.08.002
pmid: 34531138
|
| [19] |
IWAHASHI S, HASHIDA R, MATSUSE H, et al. The impact of sarcopenia on low back pain and quality of life in patients with osteoporosis[J]. BMC Musculoskelet Disord, 2022, 23(1): 142.
|
| [20] |
PARK M W, PARK S J, CHUNG S G. Relationships between skeletal muscle mass, lumbar lordosis, and chronic low back pain in the elderly[J]. Neurospine, 2023, 20(3): 959-968.
doi: 10.14245/ns.2346494.247
pmid: 37798990
|
| [21] |
KIM W J, KIM K J, SONG D G, et al. Sarcopenia and back muscle degeneration as risk factors for back pain: a comparative study[J]. Asian Spine J, 2020, 14(3): 364-372.
doi: 10.31616/asj.2019.0125
pmid: 31906616
|
| [22] |
CHUA M, HOCHBERG U, REGEV G, et al. Gender differences in multifidus fatty infiltration, sarcopenia and association with preoperative pain and functional disability in patients with lumbar spinal stenosis[J]. Spine J, 2022, 22(1): 58-63.
doi: 10.1016/j.spinee.2021.06.007
|
| [23] |
BO J, ZHAO X, HUA Z, et al. Impact of sarcopenia and sagittal parameters on the residual back pain after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fracture[J]. J Orthop Surg Res, 2022, 17(1): 111.
|
| [24] |
HO K K, LAU L C, CHAU W W, et al. End-stage knee osteoarthritis with and without sarcopenia and the effect of knee arthroplasty: a prospective cohort study[J]. BMC Geriatr, 2021, 21(1): 2.
|
| [25] |
TSUJI H, TETSUNAGA T, MISAWA H, et al. Association of phase angle with sarcopenia in chronic musculoskeletal pain patients: a retrospective study[J]. J Orthop Surg Res, 2023, 18(1): 87.
|
| [26] |
YOU M, CHEN X, LIU D, et al. ChatGPT-4 and wearable device assisted intelligent exercise therapy for co-existing sarcopenia and osteoarthritis (GAISO): a feasibility study and design for a randomized controlled PROBE non-inferiority trial[J]. J Orthop Surg Res, 2024, 19(1): 635.
|
| [27] |
HOSOYAMA T, KAWAI-TAKAISHI M, IIDA H, et al. Lack of vitamin D signalling in mesenchymal progenitors causes fatty infiltration in muscle[J]. J Cachexia Sarcopenia Muscle, 2024, 15(3): 907-918.
doi: 10.1002/jcsm.v15.3
|
| [28] |
KWON H J, KIM C S, KIM S, et al. Association between fatty infiltration in the cervical multifidus and treatment response following cervical interlaminar epidural steroid injection[J]. Korean J Pain, 2023, 36(3): 358-368.
doi: 10.3344/kjp.23092
|
| [29] |
BENNETT J L, PRATT A G, DODDS R, et al. Rheumatoid sarcopenia: loss of skeletal muscle strength and mass in rheumatoid arthritis[J]. Nat Rev Rheumatol, 2023, 19(4): 239-251.
doi: 10.1038/s41584-023-00921-9
pmid: 36801919
|
| [30] |
PAN D, YANG L, YANG X, et al. Potential nutritional strategies to prevent and reverse sarcopenia in aging process: role of fish oil-derived ω-3 polyunsaturated fatty acids, wheat oligopeptide and their combined intervention[J]. J Adv Res, 2024, 57: 77-91.
doi: 10.1016/j.jare.2023.04.005
|
| [31] |
TAAFFE D R, HENWOOD T R, NALLS M A, et al. Alterations in muscle attenuation following detraining and retraining in resistance-trained older adults[J]. Gerontology, 2009, 55(2): 217-223.
doi: 10.1159/000182084
pmid: 19060453
|
| [32] |
ZHUANG M, GU Y, WANG Z, et al. Effects of 12-week whole-body vibration training versus resistance training in older people with sarcopenia[J]. Sci Rep, 2025, 15(1): 6981.
|
| [33] |
ARNOLD W D, CLARK B C. Neuromuscular junction transmission failure in aging and sarcopenia: the nexus of the neurological and muscular systems[J]. Ageing Res Rev, 2023, 89: 101966.
doi: 10.1016/j.arr.2023.101966
|